We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALVR market cap is 85.83M. The company's latest EPS is USD -1.6694 and P/E is -0.45.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -40.43M | -43.23M | -47.3M | -46.96M | -43.84M |
Net Income | -38.14M | -41.18M | -45.27M | -44.27M | -59.7M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 165k | 0 | 0 | 0 | 0 |
Operating Income | -26.7M | -71.31M | -172.27M | -171.2M | -181.33M |
Net Income | -23.84M | -69.78M | -171.96M | -168.71M | -190.42M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 277.08M | 244.04M | 282.69M | 248.31M | 190.8M |
Total Liabilities | 52.56M | 50.51M | 53.58M | 52.98M | 45.02M |
Total Equity | 224.52M | 193.53M | 229.11M | 195.33M | 145.78M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 139.42M | 370.82M | 286.59M | 277.08M | 190.8M |
Total Liabilities | 17.8M | 17.76M | 61.33M | 52.56M | 45.02M |
Total Equity | -51.5M | 353.06M | 225.27M | 224.52M | 145.78M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -142.05M | -32.12M | -59.24M | -93.72M | -124.45M |
Investing | -80.48M | 41.72M | 79.62M | 12.77M | 37.99M |
Financing | 126.96M | N/A | 70.48M | 70.48M | 70.5M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -20.16M | -60.81M | -106.32M | -142.05M | -124.45M |
Investing | -64.64M | -169.5M | 185.98M | -80.48M | 37.99M |
Financing | 120.92M | 291.98M | 232k | 126.96M | 70.5M |
Market Cap | 85.83M |
Price to Earnings Ratio | -0.45 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.95 |
Price to Book Ratio | 0.59 |
Dividend Yield | - |
Shares Outstanding | 114.06M |
Average Volume (1 week) | 252.03k |
Average Volume (1 Month) | 338.28k |
52 Week Change | -86.94% |
52 Week High | 6.12 |
52 Week Low | 0.58 |
Spread (Intraday) | 0.06 (7.64%) |
Company Name | AlloVir Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.allovir.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions